Aziyo Biologics Inc expected to post a loss of 62  cents a share - Earnings Preview

Elutia

06/05/2022 23:17

* Aziyo Biologics Inc  AZYO.OQ   AZYO.O  is expected to show
a
fall in quarterly revenue when it reports  results on May 9. 
    * The Silver Spring Maryland-based  company is expected to
report 
a 16.4% decrease in revenue to $10.776 million from $12.88
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Aziyo Biologics Inc
is
for a loss of 62 cents per share. For the same quarter last
year, the company reported a loss of 50 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aziyo
Biologics
Inc is $11.5​, above​ its last closing price of $6.60. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.68       -0.68      -0.82     Missed  -20.1
 Sep. 30 2021  -0.62       -0.62      -0.81     Missed  -30.1
 Jun. 30 2021  -0.55       -0.53      -0.58     Missed  -8.9​
 Mar. 31 2021  -0.57       -0.57      -0.50     Beat    11.8
 ​​Dec.        -0.50       -0.50      -0.57     Missed  -13.7
 31 2020                                                
 Sep. 30 2020  -3.42       -4.37      -10.38    Missed  -137.5
                                                        ​
 This summary was machine generated May 6 at 22:16 GMT.  All
figures in US dollars  unless otherwise stated